Shoulder dystocia - Nursing Case Study

Pathophysiology

• Primary mechanism: Shoulder dystocia occurs when the fetal anterior shoulder becomes impacted behind the maternal pubic symphysis during delivery, preventing the fetus from progressing through the birth canal. This is primarily due to a discrepancy between the fetal shoulder width and the maternal pelvic size.

• Secondary mechanism: Excessive fetal size, or macrosomia, often contributes to shoulder dystocia. It leads to increased risk as the larger shoulder circumference is more likely to become lodged, especially when combined with maternal factors such as a small pelvis or abnormal pelvic shape.

• Key complication: Brachial plexus injury can occur when excessive traction is applied to resolve the dystocia, potentially leading to temporary or permanent nerve damage affecting arm movement and sensation in the newborn.

Patient Profile

Demographics:

32-year-old female, office manager

History:

• Key past medical history: Gestational diabetes, previous C-section

• Current medications: Prenatal vitamins, Metformin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Difficulty in delivering the baby's shoulders during childbirth

• Key symptoms: Prolonged labor, severe pain during contractions, decreased fetal movements

• Vital signs: Blood pressure 145/90 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.9°C

Section 1

As the labor progresses, the healthcare team closely monitors the patient, noting that the fetal heart rate is beginning to decelerate, indicating fetal distress. The patient exhibits increasing exhaustion, and her vital signs reveal a concerning trend: blood pressure has risen to 150/95 mmHg, and her heart rate is now 120 bpm. Additionally, her respiratory rate remains elevated at 26 breaths per minute, suggesting increased anxiety and stress. A quick ultrasound confirms fetal macrosomia, with an estimated fetal weight of 4.5 kg, which aligns with the mother's gestational diabetes history and the current presentation of shoulder dystocia.

The obstetric team decides to attempt the McRoberts maneuver, a non-invasive intervention to alleviate the shoulder dystocia by hyper-flexing the patient's legs tightly against her abdomen to increase the pelvic outlet diameter. This maneuver is executed with the help of nursing staff, and while it slightly improves the fetal position, it does not resolve the dystocia completely. The fetal heart rate continues to show signs of deceleration, dropping to 90 bpm, indicating ongoing fetal distress.

Recognizing the urgency, the team prepares for a potential emergency cesarean delivery while simultaneously employing suprapubic pressure to assist in dislodging the fetal shoulder. As they proceed, the patient begins to experience increased uterine contractions and reports intense pain. The combination of maneuvers eventually enables the delivery of the baby's shoulder, but not without difficulty, raising concerns about potential brachial plexus injury. The newborn is delivered shortly thereafter, but exhibits weak cry and decreased muscle tone, prompting the immediate initiation of neonatal resuscitation protocols by the neonatal team. The mother's blood pressure remains elevated, necessitating close postpartum monitoring for potential complications such as postpartum hemorrhage or hypertension-related issues.

Section 2

As the neonatal team continues resuscitative efforts, the newborn's Apgar scores are initially low, with a score of 4 at one minute, indicating significant distress. However, with consistent positive pressure ventilation and gentle stimulation, the infant's condition gradually improves, achieving a score of 7 at five minutes. Despite this positive trajectory, the neonatal team notes asymmetrical movement in the infant's left arm, raising concerns about a possible brachial plexus injury, a recognized complication of shoulder dystocia. Further assessment and a pediatric neurologist's consultation are planned to evaluate the extent of the injury and guide management.

Meanwhile, attention turns back to the mother's postpartum status. The obstetric team closely monitors her for signs of postpartum hemorrhage, given the prolonged labor and elevated blood pressure. Initial postpartum assessments reveal a uterus that is firm but slightly above the umbilicus, with moderate vaginal bleeding. Her vital signs remain concerning: blood pressure persists at 155/100 mmHg, heart rate stabilizes at 110 bpm, and respiratory rate decreases slightly to 24 breaths per minute. These findings, coupled with her gestational diabetes history, suggest an increased risk for hypertensive disorders or postpartum hemorrhage, requiring vigilant observation and potentially pharmacological intervention to manage blood pressure and prevent further complications.

Labs are promptly ordered to assess the mother's complete blood count and coagulation profile, revealing a hemoglobin level of 10 g/dL, indicating mild anemia, and a slight prolongation in prothrombin time, suggesting a potential clotting issue. These results prompt the healthcare team to initiate a low-dose magnesium sulfate infusion to prevent eclampsia, while also considering antihypertensive therapy to better control her blood pressure. As the team implements these measures, they maintain a focus on balancing the mother's fluid status and ensuring adequate uterine tone to prevent hemorrhage, setting the stage for careful monitoring and continued coordinated care in the postpartum period.

Section 3

As the medical team continues to monitor the mother postpartum, they notice a gradual change in her status. Despite the magnesium sulfate infusion, her blood pressure remains elevated, now reading 160/105 mmHg, indicating that the hypertensive crisis is not yet fully controlled. Her heart rate has increased slightly to 115 bpm, and her respiratory rate remains steady at 24 breaths per minute. The patient begins to report a persistent headache and visual disturbances, which are concerning for the development of preeclampsia with severe features. Given these changes, the team decides to escalate her antihypertensive therapy, introducing a combination of labetalol and nifedipine to better manage her blood pressure and reduce the risk of progression to eclampsia.

Meanwhile, the postpartum bleeding is being closely observed. The uterine fundus is palpated and found to be firm but now slightly more boggy than before, with an increase in the amount of lochia rubra. This change prompts the team to administer additional uterotonics, including oxytocin and methylergonovine, to enhance uterine contraction and control the bleeding. The team also considers the need for a blood transfusion given her hemoglobin level of 10 g/dL and the possibility of worsening anemia due to ongoing blood loss.

As these interventions are implemented, the healthcare team remains vigilant for any new complications. They continue to assess her fluid balance, keeping a careful eye on her intake and output to prevent fluid overload, especially in the context of her cardiac status and recent magnesium sulfate administration. The coordinated efforts aim to stabilize her condition while preparing for a potential escalation in care if her symptoms do not improve. The team is prepared for further diagnostic evaluations, including a repeat complete blood count and coagulation panel, to guide ongoing management decisions and ensure both maternal and fetal well-being in the postpartum period.

Section 4

As the medical team continues their vigilant monitoring, they note a concerning change in the patient's condition indicating new complications. Despite the introduction of labetalol and nifedipine, the blood pressure remains stubbornly high, fluctuating between 158/100 mmHg and 162/107 mmHg. The patient's complaints of a persistent headache and visual disturbances intensify, warranting further investigation. A repeat complete blood count and coagulation panel are promptly ordered to assess any underlying hematological issues that may be contributing to her deteriorating state.

The new diagnostic results reveal an alarming trend: her platelet count has dropped to 95,000/mm³, indicating thrombocytopenia, while her liver enzymes show a marked elevation, suggestive of HELLP syndrome (Hemolysis, Elevated Liver enzymes, and Low Platelet count). The patient's hemoglobin has decreased to 9 g/dL, confirming a progression in anemia. These findings correlate with the ongoing signs of preeclampsia with severe features and underscore the potential for rapid clinical deterioration.

In response, the healthcare team recalibrates their approach, prioritizing the stabilization of her hemodynamic status while mitigating the risk of eclampsia. They initiate a magnesium sulfate bolus to prevent seizure activity, closely monitor the neurological status, and consider the necessity for blood product replacement to address the thrombocytopenia and anemia. The patient's fluid balance is meticulously managed, with diuretics prescribed judiciously to avoid exacerbating the risk of pulmonary edema. The team is on high alert for any signs of further complications, prepared to escalate care to intensive monitoring if necessary. This proactive response aims to avert a critical crisis, ensuring safety and leading the patient towards a more stable recovery path.

Section 5

As the medical team continues to closely monitor the patient following the administration of magnesium sulfate, they observe a notable change in her neurological status. The patient begins to exhibit signs of increased confusion and disorientation, raising concerns about potential cerebral involvement. Her blood pressure remains elevated despite ongoing treatment, with readings consistently hovering around 160/105 mmHg. The persistent headache and visual disturbances, coupled with her altered mental state, suggest the possibility of impending eclampsia despite prophylactic measures.

In light of these developments, the team orders an urgent head CT scan to rule out cerebral edema or hemorrhage. Concurrently, they reassess her magnesium levels to ensure therapeutic dosing and prevent magnesium toxicity, given her altered sensorium. The patient's reflexes are checked regularly, revealing diminished deep tendon reflexes, which may indicate a need to adjust the magnesium dosage. Continuous fetal monitoring is maintained, as fetal distress could necessitate urgent delivery.

The diagnostic imaging reveals no acute intracranial pathology, providing some relief; however, the unchanged clinical picture necessitates a reevaluation of her treatment plan. The decision is made to escalate care to the intensive care unit for more rigorous hemodynamic monitoring and support. The team collaborates with hematology to discuss the potential need for plasma exchange or further blood product transfusions to manage her HELLP syndrome. As the patient is transferred to the ICU, the team remains vigilant, aware that swift intervention is critical in preventing further deterioration and ensuring the best possible outcome for both mother and child.